advertisement

Topcon

Jiang Y 9

Showing records 1 to 9 | Display all abstracts from Jiang Y

95077 Laser in Glaucoma and Ocular Hypertension Trial (LIGHT) in China - A Randomized Controlled Trial: Design and Baseline Characteristics
Yang Y
American Journal of Ophthalmology 2021; 230: 143-150
95302 SRp20: A potential therapeutic target for human tumors
Wang H
Pathology, research and practice 2021; 224: 153444
94432 Association of anterior segment parameters and 5-year incident narrow angles: findings from an older Chinese population
Jiang Y
British Journal of Ophthalmology 2021; 105: 970-976
95302 SRp20: A potential therapeutic target for human tumors
Jiang Y
Pathology, research and practice 2021; 224: 153444
95077 Laser in Glaucoma and Ocular Hypertension Trial (LIGHT) in China - A Randomized Controlled Trial: Design and Baseline Characteristics
Jiang Y
American Journal of Ophthalmology 2021; 230: 143-150
94432 Association of anterior segment parameters and 5-year incident narrow angles: findings from an older Chinese population
Wang W; Wang L
British Journal of Ophthalmology 2021; 105: 970-976
95077 Laser in Glaucoma and Ocular Hypertension Trial (LIGHT) in China - A Randomized Controlled Trial: Design and Baseline Characteristics
Huang S
American Journal of Ophthalmology 2021; 230: 143-150
94432 Association of anterior segment parameters and 5-year incident narrow angles: findings from an older Chinese population
He M
British Journal of Ophthalmology 2021; 105: 970-976
95077 Laser in Glaucoma and Ocular Hypertension Trial (LIGHT) in China - A Randomized Controlled Trial: Design and Baseline Characteristics
Zhang X; Nathwani N; Lin M; Liu X; Fan Y; Xu J; Gazzard G; Yu M;
American Journal of Ophthalmology 2021; 230: 143-150

Issue 22-2

Change Issue


advertisement

Topcon